Assisted Reproductive Technology Market Size, Share, Trends, Industry Analysis Report: By Type (In-Vitro Fertilization and Artificial Insemination), End Use, and Region

Description

List of Tables

The global Assisted Reproductive Technology market size is expected to reach USD 50.24 billion by 2034, according to a new study by Polaris Market Research. The report "Assisted Reproductive Technology Market Size, Share, Trends, Industry Analysis Report: By Type (In-Vitro Fertilization (IVF) and Artificial Insemination), End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The Assisted Reproductive Technology (ART) market encompasses a diverse array of medical procedures designed to address infertility challenges, ultimately aiming to facilitate conception. These techniques involve the manipulation of human reproductive cells, specifically eggs and sperm, or embryos outside of the body. The core of ART lies in overcoming natural barriers to fertilization and implantation, offering solutions for individuals and couples facing difficulties in achieving pregnancy through natural means. This market represents a significant segment within the broader healthcare industry, driven by the increasing global prevalence of infertility and the growing societal acceptance of medical interventions to achieve parenthood.

The Assisted Reproductive Technology market is experiencing substantial growth, propelled by several key factors. Rising infertility rates, influenced by delayed childbearing, lifestyle choices, and medical conditions, are a primary market drive. Furthermore, continuous advancements in ART procedures, such as improvements in In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Preimplantation Genetic Testing (PGT), are enhancing success rates and broadening the applicability of these treatments. The increasing awareness and acceptance of ART as a viable option, coupled with expanding access to fertility clinics and supportive regulatory environments in many regions, further contribute to the positive market outlook and ongoing market development of this crucial healthcare sector.

Assisted Reproductive Technology Market Report Highlights:

By type, In-vitro fertilization (IVF) currently holds the largest share of the Assisted Reproductive Technology market globally. This is primarily due to its higher success rates in addressing a broader spectrum of infertility issues compared to other ART procedures, making it the preferred choice for many facing complex fertility challenges worldwide.

By end use, fertility clinics & other facilities presently command the largest share of the Assisted Reproductive Technology market. Their specialized focus, advanced infrastructure, and concentration of expert medical professionals make them the primary destination for individuals and couples seeking comprehensive ART services globally.

By region, North America and Europe have historically been key regions, characterized by well-established healthcare infrastructure, high awareness of ART procedures, and supportive regulatory frameworks in many countries. The Asia Pacific region is emerging as a high-growth area, fueled by increasing medical tourism, rising disposable incomes, and a growing acceptance of ART as a solution for infertility.

The major players actively operating in the Assisted Reproductive Technology market include FUJIFILM Irvine Scientific, Inc., (FUJIFILM Holdings Corporation), CooperSurgical, Inc., (The Cooper Companies, Inc.), Vitrolife AB, Merck KGaA, Thermo Fisher Scientific Inc., Esco Micro Pte. Ltd., Genea Biomedx Pty Ltd, IVFtech a.s., Kitazato Corporation, and Boston IVF (IntegraMed Fertility).

Polaris Market Research has segmented the Assisted Reproductive Technology market report based on type, end use, and region:

By Type Outlook (Revenue-USD Billion, 2020-2034)

In-Vitro Fertilization (IVF)

Artificial Insemination

By End Use Outlook (Revenue-USD Billion, 2020-2034)

Fertility Clinics & other facilities

HospitalsOthers

By Regional Outlook (Revenue-USD Billion, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia-Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia-Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Product Code: PM5641

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Assisted Reproductive Technology Market Insights

4.1. Assisted Reproductive Technology Market - Market Snapshot
4.2. Assisted Reproductive Technology Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Infertility Rates Globally
  - 4.2.1.2. Technological Advancements in ART
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Treatment Costs
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Assisted Reproductive Technology Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Assisted Reproductive Technology Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
5.3. In-Vitro Fertilization (IVF)
- 5.3.1. Global Assisted Reproductive Technology Market, by In-Vitro Fertilization (IVF), by Region, 2020-2034 (USD Billion)
5.4. Artificial Insemination
- 5.4.1. Global Assisted Reproductive Technology Market, by Artificial Insemination, by Region, 2020-2034 (USD Billion)

6. Global Assisted Reproductive Technology Market, by End Use

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
6.3. Fertility Clinics & other facilities
- 6.3.1. Global Assisted Reproductive Technology Market, by Fertility Clinics & other facilities, by Region, 2020-2034 (USD Billion)
6.4. Hospitals
- 6.4.1. Global Assisted Reproductive Technology Market, by Hospitals, by Region, 2020-2034 (USD Billion)
6.5. Others
- 6.5.1. Global Assisted Reproductive Technology Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Assisted Reproductive Technology Market, by Geography

7.1. Key Findings
7.2. Introduction
- 7.2.1. Assisted Reproductive Technology Market Assessment, By Geography, 2020-2034 (USD Billion)
7.3. Assisted Reproductive Technology Market - North America
- 7.3.1. North America: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
- 7.3.2. North America: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.3.3. Assisted Reproductive Technology Market - U.S.
  - 7.3.3.1. U.S.: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.3.3.2. U.S.: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.3.4. Assisted Reproductive Technology Market - Canada
  - 7.3.4.1. Canada: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.3.4.2. Canada: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
7.4. Assisted Reproductive Technology Market - Europe
- 7.4.1. Europe: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
- 7.4.2. Europe: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.4.3. Assisted Reproductive Technology Market - UK
  - 7.4.3.1. UK: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.4.3.2. UK: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.4.4. Assisted Reproductive Technology Market - France
  - 7.4.4.1. France: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.4.4.2. France: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.4.5. Assisted Reproductive Technology Market - Germany
  - 7.4.5.1. Germany: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.4.5.2. Germany: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.4.6. Assisted Reproductive Technology Market - Italy
  - 7.4.6.1. Italy: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.4.6.2. Italy: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.4.7. Assisted Reproductive Technology Market - Spain
  - 7.4.7.1. Spain: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.4.7.2. Spain: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.4.8. Assisted Reproductive Technology Market - Netherlands
  - 7.4.8.1. Netherlands: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.4.8.2. Netherlands: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.4.9. Assisted Reproductive Technology Market - Russia
  - 7.4.9.1. Russia: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.4.9.2. Russia: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.4.10. Assisted Reproductive Technology Market - Rest of Europe
  - 7.4.10.1. Rest of Europe: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.4.10.2. Rest of Europe: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
7.5. Assisted Reproductive Technology Market - Asia Pacific
- 7.5.1. Asia Pacific: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
- 7.5.2. Asia Pacific: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.5.3. Assisted Reproductive Technology Market - China
  - 7.5.3.1. China: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.5.3.2. China: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.5.4. Assisted Reproductive Technology Market - India
  - 7.5.4.1. India: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.5.4.2. India: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.5.5. Assisted Reproductive Technology Market - Malaysia
  - 7.5.5.1. Malaysia: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.5.5.2. Malaysia: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.5.6. Assisted Reproductive Technology Market - Japan
  - 7.5.6.1. Japan: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.5.6.2. Japan: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.5.7. Assisted Reproductive Technology Market - Indonesia
  - 7.5.7.1. Indonesia: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.5.7.2. Indonesia: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.5.8. Assisted Reproductive Technology Market - South Korea
  - 7.5.8.1. South Korea: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.5.8.2. South Korea: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.5.9. Assisted Reproductive Technology Market - Australia
  - 7.5.9.1. Australia: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.5.9.2. Australia: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.5.10. Assisted Reproductive Technology Market - Rest of Asia Pacific
  - 7.5.10.1. Rest of Asia Pacific: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.5.10.2. Rest of Asia Pacific: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
7.6. Assisted Reproductive Technology Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
- 7.6.2. Middle East & Africa: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.6.3. Assisted Reproductive Technology Market - Saudi Arabia
  - 7.6.3.1. Saudi Arabia: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.6.3.2. Saudi Arabia: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.6.4. Assisted Reproductive Technology Market - UAE
  - 7.6.4.1. UAE: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.6.4.2. UAE: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.6.5. Assisted Reproductive Technology Market - Israel
  - 7.6.5.1. Israel: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.6.5.2. Israel: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.6.6. Assisted Reproductive Technology Market - South Africa
  - 7.6.6.1. South Africa: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.6.6.2. South Africa: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.6.7. Assisted Reproductive Technology Market - Rest of Middle East & Africa
  - 7.6.7.1. Rest of Middle East & Africa: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.6.7.2. Rest of Middle East & Africa: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
7.7. Assisted Reproductive Technology Market - Latin America
- 7.7.1. Latin America: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
- 7.7.2. Latin America: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.7.3. Assisted Reproductive Technology Market - Mexico
  - 7.7.3.1. Mexico: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.7.3.2. Mexico: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.7.4. Assisted Reproductive Technology Market - Brazil
  - 7.7.4.1. Brazil: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.7.4.2. Brazil: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.7.5. Assisted Reproductive Technology Market - Argentina
  - 7.7.5.1. Argentina: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.7.5.2. Argentina: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)
- 7.7.6. Assisted Reproductive Technology Market - Rest of Latin America
  - 7.7.6.1. Rest of Latin America: Assisted Reproductive Technology Market, by Type, 2020-2034 (USD Billion)
  - 7.7.6.2. Rest of Latin America: Assisted Reproductive Technology Market, by End Use, 2020-2034 (USD Billion)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Boston IVF (IntegraMed Fertility)
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. CooperSurgical, Inc. (The Cooper Companies, Inc.)
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. Esco Micro Pte. Ltd.
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. FUJIFILM Irvine Scientific, Inc. (FUJIFILM Holdings Corporation)
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. Genea Biomedx Pty Ltd
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. IVFtech a.s.
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Kitazato Corporation
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Merck KGaA
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. Thermo Fisher Scientific Inc.
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. Vitrolife AB
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development